vs

Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and BIOLIFE SOLUTIONS INC (BLFS). Click either name above to swap in a different company.

BIOLIFE SOLUTIONS INC is the larger business by last-quarter revenue ($18.8M vs $11.9M, roughly 1.6× ASCENT INDUSTRIES CO.). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs -8.8%, a 67.7% gap on every dollar of revenue. On growth, BIOLIFE SOLUTIONS INC posted the faster year-over-year revenue change (24.3% vs 13.3%). Over the past eight quarters, BIOLIFE SOLUTIONS INC's revenue compounded faster (1.0% CAGR vs -34.9%).

Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

ACNT vs BLFS — Head-to-Head

Bigger by revenue
BLFS
BLFS
1.6× larger
BLFS
$18.8M
$11.9M
ACNT
Growing faster (revenue YoY)
BLFS
BLFS
+11.0% gap
BLFS
24.3%
13.3%
ACNT
Higher net margin
BLFS
BLFS
67.7% more per $
BLFS
58.9%
-8.8%
ACNT
Faster 2-yr revenue CAGR
BLFS
BLFS
Annualised
BLFS
1.0%
-34.9%
ACNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNT
ACNT
BLFS
BLFS
Revenue
$11.9M
$18.8M
Net Profit
$-1.0M
$11.1M
Gross Margin
14.6%
Operating Margin
-21.0%
7.2%
Net Margin
-8.8%
58.9%
Revenue YoY
13.3%
24.3%
Net Profit YoY
-1.2%
-11.1%
EPS (diluted)
$-0.11
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNT
ACNT
BLFS
BLFS
Q4 25
$11.9M
$18.8M
Q3 25
$19.7M
$28.1M
Q2 25
$18.7M
$25.4M
Q1 25
$24.7M
$23.9M
Q4 24
$10.5M
$15.1M
Q3 24
$20.9M
$21.4M
Q2 24
$21.5M
$19.7M
Q1 24
$28.0M
$18.4M
Net Profit
ACNT
ACNT
BLFS
BLFS
Q4 25
$-1.0M
$11.1M
Q3 25
$-2.1M
$621.0K
Q2 25
$6.3M
$-15.8M
Q1 25
$-2.3M
$-448.0K
Q4 24
$-1.0M
$12.5M
Q3 24
$-6.2M
$-1.7M
Q2 24
$-926.0K
$-20.7M
Q1 24
$-5.5M
$-10.2M
Gross Margin
ACNT
ACNT
BLFS
BLFS
Q4 25
14.6%
Q3 25
29.7%
Q2 25
26.1%
Q1 25
19.3%
Q4 24
24.3%
Q3 24
14.4%
Q2 24
13.1%
Q1 24
8.3%
Operating Margin
ACNT
ACNT
BLFS
BLFS
Q4 25
-21.0%
7.2%
Q3 25
-4.1%
-0.3%
Q2 25
-14.4%
-65.5%
Q1 25
-4.2%
-5.1%
Q4 24
-25.4%
3.6%
Q3 24
-9.4%
-2.0%
Q2 24
-8.6%
-6.6%
Q1 24
-15.5%
-17.9%
Net Margin
ACNT
ACNT
BLFS
BLFS
Q4 25
-8.8%
58.9%
Q3 25
-10.6%
2.2%
Q2 25
33.7%
-62.3%
Q1 25
-9.3%
-1.9%
Q4 24
-9.8%
82.5%
Q3 24
-29.5%
-8.0%
Q2 24
-4.3%
-105.1%
Q1 24
-19.7%
-55.4%
EPS (diluted)
ACNT
ACNT
BLFS
BLFS
Q4 25
$-0.11
$0.23
Q3 25
$-0.22
$0.01
Q2 25
$0.65
$-0.33
Q1 25
$-0.23
$-0.01
Q4 24
$-0.11
$0.27
Q3 24
$-0.61
$-0.04
Q2 24
$-0.09
$-0.45
Q1 24
$-0.54
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNT
ACNT
BLFS
BLFS
Cash + ST InvestmentsLiquidity on hand
$57.6M
$33.0M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$87.0M
$371.9M
Total Assets
$111.9M
$405.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNT
ACNT
BLFS
BLFS
Q4 25
$57.6M
$33.0M
Q3 25
$58.0M
$29.5M
Q2 25
$60.5M
$31.9M
Q1 25
$14.3M
$66.9M
Q4 24
$16.1M
$91.5M
Q3 24
$8.5M
$24.0M
Q2 24
$3.6M
$22.0M
Q1 24
$1.3M
$29.7M
Total Debt
ACNT
ACNT
BLFS
BLFS
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$0
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Q1 24
$24.3M
Stockholders' Equity
ACNT
ACNT
BLFS
BLFS
Q4 25
$87.0M
$371.9M
Q3 25
$87.1M
$353.7M
Q2 25
$89.7M
$347.2M
Q1 25
$91.2M
$352.6M
Q4 24
$93.5M
$348.9M
Q3 24
$94.7M
$325.5M
Q2 24
$101.0M
$321.4M
Q1 24
$102.0M
$333.4M
Total Assets
ACNT
ACNT
BLFS
BLFS
Q4 25
$111.9M
$405.9M
Q3 25
$119.9M
$392.1M
Q2 25
$122.6M
$387.2M
Q1 25
$152.5M
$395.1M
Q4 24
$147.3M
$399.5M
Q3 24
$148.6M
$381.7M
Q2 24
$158.2M
$375.0M
Q1 24
$161.0M
$401.6M
Debt / Equity
ACNT
ACNT
BLFS
BLFS
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.00×
0.05×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNT
ACNT
BLFS
BLFS
Operating Cash FlowLast quarter
$266.0K
$4.9M
Free Cash FlowOCF − Capex
$-196.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.44×
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNT
ACNT
BLFS
BLFS
Q4 25
$266.0K
$4.9M
Q3 25
$1.3M
$6.1M
Q2 25
$-1.4M
$7.4M
Q1 25
$-700.0K
$1.7M
Q4 24
$8.8M
$1.6M
Q3 24
$3.4M
$4.8M
Q2 24
$2.2M
$6.5M
Q1 24
$263.0K
$-4.5M
Free Cash Flow
ACNT
ACNT
BLFS
BLFS
Q4 25
$-196.0K
Q3 25
$695.0K
Q2 25
$-1.5M
Q1 25
$-1.0M
Q4 24
$8.4M
Q3 24
$3.1M
Q2 24
$1.9M
Q1 24
$25.0K
FCF Margin
ACNT
ACNT
BLFS
BLFS
Q4 25
-1.7%
Q3 25
3.5%
Q2 25
-8.3%
Q1 25
-4.1%
Q4 24
80.6%
Q3 24
15.1%
Q2 24
9.1%
Q1 24
0.1%
Capex Intensity
ACNT
ACNT
BLFS
BLFS
Q4 25
3.9%
Q3 25
3.1%
Q2 25
0.8%
Q1 25
1.3%
Q4 24
3.7%
Q3 24
1.3%
Q2 24
1.0%
Q1 24
0.9%
Cash Conversion
ACNT
ACNT
BLFS
BLFS
Q4 25
0.44×
Q3 25
9.83×
Q2 25
-0.22×
Q1 25
Q4 24
0.13×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACNT
ACNT

Other$6.1M52%
Transferred At Point In Time$5.7M48%

BLFS
BLFS

Segment breakdown not available.

Related Comparisons